ArticleMolecular medicine (Cambridge, Mass.)2022

Clinical application of RUBCN/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease.

Mona M Watany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.